Eacom Timber Company Description
New name, new game. Formerly Inflazyme Pharmaceuticals, Eacom Timber Corporation has left behind the world of respiratory disease research for a foray into the wild world of lumber and forestry. In 2007 the company halted its development activities and later sold its assets to a private Swedish drug company called Biolipox. A 2008 deal to merge with medical device firm Z-Tech (Canada) later fell through, and the company eventually opted to abandon the health field completely and target the forestry and lumber industry.
View the Comprehensive Company Description for Eacom Timber
The Company Description provides a historical perspective of Eacom Timber's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Eacom Timber's evolution in the marketplace.
